• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media

Google+

Be a CRA at PRA. We will be at #ACRP2015. http://www.acrp2015.org/. Stop by booth #501 for an interview...


View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences to Report First Quarter 2015 Results

17 April 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2015 results after the market closes on Wednesday, May 6, 2015. The Company will also...

PRA Health Sciences to Add New Jobs in Swansea

17 April 2015, Raleigh, N.C. – PRA Health Sciences (PRA), a leading global clinical research organization, is expanding its business in Swansea with the creation of 87 new jobs. The...

PRA Health Sciences Expands Global Phase I Patient Strategy

PRA Health Sciences (PRA) is enhancing its global Phase I patient strategy and increasing its clinical footprint with the expansion of its Early Development Services (EDS). These initiatives are...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.

FACT SHEET: CNS

PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.

Events

Find out what's happening next on PRA's event schedule

3rd ANNUAL BIOSIMILARS & BIOBETTERS CONGRESS 2015
April 20 - April 21

Oxford Global Conferences are proud to present the 3rd Annual Biosimilars & Biobetters Congress, taking place on 20 – 21 April 2015 in London, UK. The congress is an exclusive opportunity for over 350 biologics experts to exchange their experiences, engage in scientific discussions and debate the best practices and solutions to improve the biosimilars […]

9TH DIA ANNUAL CONFERENCE IN JAPAN FOR ASIAN NEW DRUG DEVELOPMENT
April 20 - April 21

In addition to being the fastest growing market for pharmaceuticals, accessible patient populations and the growing infrastructure for quality conduct of clinical trial makes Asia attractive for global clinical development and a need for local regulatory authorities to quickly bring their processes and guidelines up to date and in alignment with the changing clinical trial […]

PARTNERSHIPS IN CLINICAL TRIALS (US)
April 22 - April 24

Delegates from all parts of the clinical trial value chain come to Partnerships in Clinical Trials to quickly identify, engage and enter into strategic relationships that drive their clinical trials successfully forward as well as take part in the 60+ sessions and workshops geared to focus on several topic areas of interest including but not […]

Read More >